IMPACT: Interim Physical Activity Trial Results for Pediatric Cancer Patients, 2022-2024

93 patients were referred to the IMPACT physical activity intervention trial between March 2022 and December 2024. The dataset contains interim implementation and effectiveness metrics, including referral sources, participation rates, session adherence, and pre/post-intervention quality-of-life scores. It was authored by Emma McLaughlin and shared under a CC-BY-4.0 license.

Use Cases

• Analyzing implementation metrics like referral and participation rates to understand trial reach.
• Evaluating intervention fidelity and adherence based on reported session completion percentages.
• Assessing preliminary effectiveness by examining individual change scores in quality of life and physical fitness.
• Informing quality improvement cycles for clinical trial recruitment and data collection procedures.

Strengths

• Includes specific interim metrics: 93 referrals, 12 completions, 57% session adherence, 95.2% intervention fidelity.
• Covers a defined time period from March 2022 to December 2024.
• Data informed concrete quality improvements like refined recruitment posters and videos.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• The dataset is small (1.2 MB), indicating limited scale for broad statistical analysis.

Provenance

Source

Emma McLaughlin, via figshare.

Collection Method

Data collected as part of the hybrid effectiveness-implementation IMPACT trial.

Time Range

March 2022 to December 2024

Freshness

Last updated 2026-03-17 13:09:25